a modified version of natural human insulin, synthesized by a genetically programmed strain of nonpathogenic Escherichia coli, in which the amino acids lysine (Lys) and proline (Pro) near the end of the B chain are transposed. This chemical alteration yields an insulin with a much faster onset of action, which reaches its peak effect earlier than regular insulin. [Lys + Pro]
